Daiichi Sankyo has inventory buffer, will expand production capacity in Ohio to mitigate US tariffs - CFO

Daichii Sankyo's CFO Koji Ogawa tells CNBC's Squawk Box Asia what the pharma company is doing to mitigate the effects of U.S. tariffs, including optimizing its supply chain and expanding its production facility in Ohio.